Register now for free!

Over 100,000 doctors have already joined Xpeer — register now to find out why, and get instant access to this course and many more.

I already have an account
Course Preview

Cardiovascular Inflammation: From Risk Assessment to Landmark Trials and Future Directions

5

Accredited (Credits: 1)
Free
1h
Live

Synopsis

This CME-accredited live webinar will examine how cardiovascular inflammation can be assessed in current clinical practice and how the evidence for targeting inflammation has developed over time. The faculty will discuss residual inflammatory risk and the role and limitations of hsCRP and other biomarkers within the wider cardiovascular risk profile. The webinar will then review landmark outcomes evidence from CANTOS through subsequent positive and neutral trials, including the latest evidence from ZEUS. The discussion will consider how biological pathway, patient selection and clinical timing influence outcomes, while identifying the questions that must still be addressed before inflammatory assessment and targeted treatment can be integrated more routinely into cardiovascular care. This activity is financially supported by Novo Nordisk. Novo Nordisk has had no influence on the content of this course. All information and all opinions provided and express in this course are under the sole responsibility of Xpeer Meded S.L.

Objectives

After completing this activity, participants should be better prepared to:

  • Interpret hsCRP and other inflammatory biomarkers within the wider cardiovascular risk profile.
  • Identify persistent inflammatory risk despite management of conventional cardiovascular risk factors.
  • Compare findings from landmark cardiovascular inflammation outcomes trials.
  • Evaluate how biological target, patient selection and clinical timing influence cardiovascular outcomes.

Accreditation

This course is accredited with 1 ECMEC credit valid in 26 countries. To claim your credits take the evaluation (satisfaction survey and evaluation questionnaire). You have 3 attempts for the evaluation. You need to pass the evaluation with a sufficient score to validate the course. Your diploma is issued instantaneously and sent to your email.

See more information on the accreditation at: Accreditation

Duration

1h

Target audience

Cardiology, Internal medicine, General practice, Family medicine, Doctor / Physician

Authors

Prof. Paul Ridker

Prof. Paul M. Ridker is the Eugene Braunwald Professor of Medicine at Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital in Boston, USA. An internationally recognized expert in cardiovascular inflammation and preventive cardiology, his research focuses on inflammatory biomarkers, atherosclerosis, and cardiovascular risk reduction. He has led landmark clinical trials, including JUPITER and CANTOS, advancing the understanding of inflammation in cardiovascular disease.

Testimonials

“I've taken several courses on Xpeer and they've been very useful. The format is very dynamic, allowing you to watch the videos in your free time since they're no longer than 15 minutes. The topics are very current.”

Francisco P. onTrustpilot

Spain

“Excellent platform to stay up to date and keep learning throughout your professional career. I recommend it to all my colleagues.”

Omar I. onTrustpilot

Spain

“Xpeer is a magnificent platform for healthcare professionals, where you can gain knowledge from a scientific and highly up-to-date perspective across various medical specialties.”

Wil A. onTrustpilot

Netherlands

Read more reviews onTrustpilot

FAQs